Abliva
Develops medicines for the treatment of primary mitochondrial diseases.
HQ location
Lund Municipality, Sweden
Website
Launch date
Employees
Market cap
$86.7m
Enterprise value
$83m
Share price
SEK0.44 ABLI.ST
Company register number
556595-6538
Recent deals
Authorizing premium user...